BLRX
BioLineRX
BLRX
BLRX
28 hedge funds and large institutions have $43.4M invested in BioLineRX in 2017 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 8 increasing their positions, 3 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
28
Holders Change
–
Holders Change %
0%
% of All Funds
0.7%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
5
Increased
8
Reduced
3
Closed
5
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
26
UBS Group
Zurich,
Switzerland
| $2K | +$2K | +3 | New |
|
|
KF
27
Krilogy Financial
St. Louis,
Missouri
| $1K | – | – | – |
|
28
Wells Fargo
San Francisco,
California
| $1K | – | – | – |
|
|
RE
29
RBC Europe
London,
United Kingdom
| $224 | – | – | – |
|
|
SM
30
Sabby Management
Miami Beach,
Florida
| – | -$2.51M | -4,915 | Closed |
|
|
DCM
31
DAFNA Capital Management
Los Angeles,
California
| – | -$828K | -1,634 | Closed |
|
32
Alyeska Investment Group
Chicago,
Illinois
| – | -$743K | -1,466 | Closed |
|
33
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| – | -$126K | -247 | Closed |
|
|
ARTA
34
A.R.T. Advisors
New York
| – | -$21K | -41 | Closed |
|